I just want you to know if it wasn't for Mr.Schissler CCEL stock would still be in the preverbal toilet. Your CEO has had 14 years of trying to raise the PPS and along comes CBAI acquiring business;s and one of the only Cord Blood banks taking on the faltering CB banks within the new industry. WHO do you think will be heading up the CB CEO's in order for all of them to put a value on a stemcell sample. most likely the one who has acquired the most!
Matt has done the industry a huge favor! and trust me he will end up on top!!
CCEL TANGLING WITH CBAI IN COURT WAS THE BEST THING THAT EVER HAPPENED TO THEIR PPS
It will all play out very soon!...And all companies will owe a debt of gratitude to CBAI for making the market from which CB is valued!
If you disagree with the above just ask yourself how much is a sample worth, you couldn't come up with a value. neither could other companies...their haven;t been any comps to compare to until CBAI WENT ON A RAMPAGE
How Long was it before CCEL Became Profitable HOW LONG, DID I HEAR HOW LONG 14 YEARS Would Somebody give Mercedes a Medal, Because Matt Schissler is Going to Become Profitable ALOT SOONER THAN 14 YEARS .STAY TUNED